Informed Consent and Disagreeing Parents/Guardians

This Q&A document was developed to support immunization providers when there is disagreement between Parents/Guardians who both have the authority to consent to their child's immunization.

• Informed consent and disagreement between Parents/Guardians who both have the authority to consent to their child's immunization: Questions and Answers (July  2022)
  

COVID-19 Immunization Program

A health care provider Q&A page has been created specifically for the COVID-19 immunization program. The Q&A document includes general information about COVID-19 vaccines and questions and answers specific to the vaccines currently in use in BC.

Tdap Vaccination During Pregnancy

Beginning November 2020, Tdap (tetanus, diphtheria and pertussis) vaccine will be provided free to people who are pregnant in every pregnancy. Vaccination is recommended at 27-32 weeks of gestation but it may be given from 13 weeks up to the time of delivery. The aim of this new program is to protect newborn infants in BC from severe outcomes related to pertussis infection. It is anticipated that Tdap vaccine will be provided mainly by prenatal care providers including family doctors and midwives, but can also be provided by specialty prenatal care service providers and by community-based pharmacists, or at the local health unit at adult immunization clinics.

• Tdap (tetanus, diphtheria and pertussis) Vaccination During Pregnancy Q&A (October 2020)

Vaccine Status Reporting Regulation (VSRR)

Vaccine Status Reporting Regulation Information for Health Care Providers - Q&A (Jan 2020)

Part 3 - Managament of Anaphylaxis in a Non-Hospital Setting

• Update to Part 3 - Management of Anaphylaxis in a Non-Hospital Setting Q&A (Feb 2019)
  

Part 4 - Biological Products

COVID-19 Vaccine

• COVID-19 immunization program Q&A (Jan 2021) 

Hepatitis A vaccine

• Hepatitis A for Aboriginal persons - Q&A (Mar 2012)
  

HPV vaccines

• Updates to the HPV immunization program Q&A (Aug 2017)
  
• Use of the 9-valent HPV vaccine in the Grade 6 immunization program Q&A  (Aug 2016)
  
• Expanded eligibility for HPV vaccination for select male populations Q&A (Aug 2015)
  
• HPV 2 Dose Program Q&A (Oct 2014)
• School Based HPV Vaccine 3 Dose Extended Schedule
  
• Health Care Professionals Questions and Answers (Jul 2013)
• HPV one time program for women 26 and under
  
• Clinical Q&A (Jul 2013)
  
• Programmatic Q&A (Jul 2013)
• Fact sheet and immunization record form (Jul 2013)

INFANRIX vaccines

• Infanrix vaccines Q&A (Apr 2014)
• Questions and Answers about INFANRIX hexa (Dec 2008)
  

Influenza vaccines

• Fluzone® High-Dose Quadrivalent Influenza Vaccine Q&A (Aug 2021)
• Fluzone® HIgh-Dose Influenza Vaccine Q&A (Aug 2020)
  
• Fluzone® High-Dose Influenza Vaccine Q&A (Aug 2019)
  
• Fluzone® High-Dose Influenza Vaccine Q&A (Aug 2018)
• 2016/17 Rationale for Use of FluMist and Q&A (PHAC)
  
• Influenza vaccine recommendations for children with neurologic and neurodevelopmental contitions - 2015-16
• Quadrivalent influenza vaccine Q&A - 2015-16
• Flumist Q&A - 2014-15
  
• Flumist Q&A - 2013-14
• Supplemental influenza vaccine Q&A - 2013-14

MMRV vaccine

• Proquad Q&A (Apr 2014)
  

Meningococcal vaccine

• Meningococcal quadrivalent vaccine for grade 9 students
  
• Men-C-ACYW-135 Program Q&A (May 2016)

Pneumococcal conjugate (PCV13) vaccine

• PCV13 for HIV infected individauls Q&A (Apr 2015)
  

Rotavirus vaccine

• Update to the rotavirus immunization program: product change Q&A (May 2018)
  
• Rotavirus vaccine program in BC - Q&A (Feb 2012)
  

Varicella vaccine

• Two dose varicella vaccine Q&A (Sep 2012)